Designing a Novel Multi-Epitope Trivalent Vaccine Against NDV, AIV and FAdV-4 Based on Immunoinformatics Approaches
Open Access
- 2 December 2025
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 13 (12) , 2744
Abstract
The diseases caused by genotype VII Newcastle disease virus (NDV), H9N2 avian influenza virus (AIV), and fowl adenovirus serotype 4 (FAdV-4) continue to threaten the global poultry industry. However, no broad-spectrum vaccines provide simultaneous protection against these three pathogens. This study employed bioinformatics and immunoinformatics approaches to design a multi-epitope vaccine, named NFAF, which consists of B-cell, cytotoxic T lymphocyte (CTL) epitopes, and helper T lymphocyte (HTL) epitopes derived from hemagglutinin-neuraminidase (HN) and fusion (F) proteins of genotype VII NDV, hemagglutinin (HA) protein of H9N2, and Fiber2 protein of FAdV-4. The vaccine candidate was predicted to have non-allergenic properties, non-toxicity, high antigenicity, and favorable solubility. Each of its constituent antigenic epitopes has a high degree of conservation. Molecular docking demonstrated stable binding between NFAF and chicken Toll-like receptor (TLRs) and major histocompatibility complex (MHC) molecules. NFAF was expressed in soluble form in Escherichia coli and purified. Polyclonal antibodies against all three target viruses showed specific binding to NFAF. In vitro experiments revealed that NFAF effectively stimulated chicken peripheral blood mononuclear cells (PBMCs) and induced Th1, Th2, and pro-inflammatory cytokine production, confirming its immunogenicity, and increased the mRNA expression of the key signaling molecules MyD88 and NF-κB. These results suggested that NFAF could therefore be an efficacious multi-epitope vaccine against genotype VII NDV, H9N2, and FAdV-4 infections.Keywords
Funding Information
- Talents Introduction Projects of Hebei Agricultural University (YJ201945)
This publication has 35 references indexed in Scilit:
- Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza VirusACS Nano, 2025
- Leveraging artificial intelligence in vaccine development: A narrative reviewJournal of Microbiological Methods, 2024
- In silico design of a novel multi-epitope vaccine against HCV infection through immunoinformatics approachesInternational Journal of Biological Macromolecules, 2024
- Designing a Novel Multiepitope Vaccine from the Human Papilloma Virus E1 and E2 Proteins for Indonesia with Immunoinformatics and Molecular Dynamics ApproachesACS Omega, 2024
- Development of an ELISA for the detection of fowl adenovirus serotype −4 utilizing fiber proteinBiologicals, 2024
- In silico design of a promiscuous chimeric multi-epitope vaccine against Mycobacterium tuberculosisComputational and Structural Biotechnology Journal, 2023
- Multiantigen epitope fusion recombinant proteins from capsids of serotype 4 fowl adenovirus induce chicken immunity against avian Angara diseaseVeterinary Microbiology, 2023
- Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virusInfection, Genetics and Evolution, 2019
- Immunogenicity and protective efficacy of recombinant fiber-2 protein in protecting SPF chickens against fowl adenovirus 4Vaccine, 2018
- A novel conformational B-cell epitope prediction method based on mimotope and patch analysisJournal of Theoretical Biology, 2016